Certainly looking strong, I think the statement from the company yesterday clearly states up the reality of the situation -
Once the mid cycle review comes in as positive, BOT is de-risked which equates to a more realistic valuation of the business, we go from speculation/risk on, to a risk off cash flow positive business.
The fact that SP could become a first line treatment option (after OTC) puts it miles ahead of Qbrexza.
Exciting times for share holders.
Congrats to all!
Bot Chart, page-5765
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.020(5.00%) |
Mkt cap ! $689.3M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 38.0¢ | $2.264M | 5.785M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 790722 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 231350 | 4 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |